Dr. Althea, the rising Korean skincare brand known for its science-driven yet gentle, vegan formulas and viral products like the 345 Relief Cream. In a strategic partnership with Ulta Beauty, Dr. Althea debuted in 109 Ulta stores nationwide, beginning a retail rollout that will see the brand in 1,350 Ulta Beauty locations by February 2026—making K-beauty more accessible than ever for American skincare lovers.
“From the beginning, Dr. Althea was created to simplify sophisticated Korean skincare through formulas that combine clinical precision with gentle care,” said Evelyn Lee, Founder of Dr. Althea. “As our community has grown worldwide, expanding into Ulta Beauty allows us to bring that philosophy to even more people seeking balance between innovation and sensitivity. This launch is an important step in sharing our belief that effective skincare should also feel effortless.”
Why Dr. Althea’s U.S. Entry Matters
Dr. Althea has built explosive momentum stateside. Its 345…
Relief Cream—a TikTok sensation—has sold over 15 million units worldwide and propelled the brand to 1,415% North American sales growth in two years since U.S. market entry.
Nationwide Rollout: Details and Timeline The Ulta partnership began online in September 2025, followed by the physical store launch in 109 locations on October 26.
By February 2026, the brand’s cult-favorite formulas will be in every Ulta Beauty across the U.S.—1,350 doors total—alongside other top K-beauty and global indie brands. According to Accio Trends Analysis, Dr.
Althea’s partnership with Ulta has led to a notable surge in both sales and online search activity, underscoring the value of strategic retail expansion…
Members-only article
Unlock the rest of this story
Join free to keep reading RetailBoss beauty coverage, industry analysis, and market intelligence.
- Full article access
- Industry analysis
- Free account
Free access. No credit card required. Your account is created after you verify your email.
Discussion
0 Comments
No comments yet
Start the conversation
Share your take on this story and help shape the discussion.
Sign in to join the discussion.